A new immunosuppressive agent, FK506, inhibits the expression of alloantigen-activated suppressor cells as well as the induction of alloreactivity.
Yoshimura
N
N
Second Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Matsui
S
S
Hamashima
T
T
Lee
C J
CJ
Oka
T
T
D002478:Cells, Cultured; D003524:Cyclosporins / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007376:Interleukin-2 / Q000276:immunology; D007519:Isoantigens / Q000276:immunology*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D008213:Lymphocyte Activation; D011725:Pyridines / Q000494:pharmacology*; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis / Q000187:drug effects; D011990:Receptors, Transferrin / Q000096:biosynthesis / Q000187:drug effects; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology*; D016559:Tacrolimus
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D007519:Isoantigens; D011725:Pyridines; D015375:Receptors, Interleukin-2; D011990:Receptors, Transferrin; D016559:Tacrolimus